Abstract： Objective： To observe the clinical efficacy of Yishen Bugan Prescription combined with dynamic traction in treating cervical spondylotic radiculopathy （CSR） of liver-kidney deficiency type. Methods： A total of 72 patients with CSR of liver-kidney deficiency type who attended the outpatient clinic of the First Department of Spinal Diseases at Zhanjiang First Hospital of Chinese Medicine from June 2024 to June 2025 were enrolled and randomly divided into a trial group and a control group using a random number table method，with 36 cases in each group. The control group received oral Yishen Bugan Prescription， while the trial group received Yishen Bugan Prescription combined with dynamic traction. Both groups were treated continuously for one week. Visual Analogue Scale （VAS） scores of pain，Neck Disability Index （NDI） scores，Tanaka's 20-Point Cervical Spondylosis Symptom Scale scores， and traditional Chinese medicine syndrome scores were assessed before and after treatment. White blood cell （WBC） count and C-reactive protein （CRP） levels were measured. Clinical efficacy and patient satisfaction rate were compared between the two groups，and safety was evaluated. Results：After treatment，the total effective rate in the trial group was higher than that in the control group （P＜0.05）. The VAS scores，NDI scores，and traditional Chinese medicine syndrome scores decreased in both groups compared to before treatment，while Tanaka's 20-Point Cervical Spondylosis Symptom Scale scores increased，with statistically significant differences （P＜0.05）. The trial group showed lower VAS scores， NDI scores， and traditional Chinese medicine syndrome scores， and higher Tanaka's 20-Point Cervical Spondylosis Symptom Scale scores than the control group，with statistically significant differences （P＜0.05）. The WBC count and CRP levels decreased in both groups compared to before treatment （P＜0.05），and the trial group had lower WBC count and CRP levels than the control group （P＜0.05）. The overall satisfaction rate in the trial group was higher than that in the control group （P＜0.05）. No significant adverse reactions were observed in either group during treatment. Conclusion： Yishen Bugan Prescription combined with dynamic traction demonstrates definite efficacy in treating CSR of liver-kidney deficiency type. It can effectively relieve neck pain， improve cervical spine function， reduce inflammatory responses，and exhibits good clinical safety and high patient satisfaction rate.